Save time and get answers to complex questions with AI chat
Xenazine current manufacturer 2025?Alogliptin benzoate cost?Brenzavvy discontinuation?Pramlintide fda approval date?Lipitor vs generics what's the price gap?
See the DrugPatentWatch profile for Nicardipine
Nicardipine is a dihydropyridine calcium channel blocker. Its mechanism is: - It blocks L-type ( Cav1.2 ) voltage-gated calcium channels in vascular smooth muscle cells. - This reduces Ca2+ influx during depolarization, lowering intracellular calcium. - Lower Ca2+ decreases activation of the calmodulin–MLC kinase pathway, causing relaxation of smooth muscle. - Result: arteriolar (mostly arterial) vasodilation → reduced systemic vascular resistance and afterload, lower blood pressure. - Effects on veins are minimal; reflex tachycardia can occur due to the BP drop. - Nicardipine also increases coronary vasodilation, improving coronary blood flow. - It has relatively greater vascular selectivity compared with non-DHP calcium channel blockers.
Other Questions About Nicardipine :